Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of medicines for
Sanofi India Ltd Q3FY25; 34% fall in Profits
Categories
medicines
Ipca Laboratories Ltd Q2FY25; 81% rise in Profits
Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals. Financial Results: Ipca Laboratories Ltd reported Revenues for Q2FY25 of ₹2,355.00
Zydus Lifesciences Ltd Q1FY24; 97% rise in Profits
In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble
Pfizer Ltd Q1FY25; 61% rise in Profits
Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also
Pfizer Ltd Q4FY24; 38% rise in Profits
Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also
Sanofi India Ltd Q4FY24; 28% fall in Profits
Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products. Financial Results: Sanofi India Ltd reported Revenues for Q4FY24
Solara Active Pharma Sciences Ltd Q2FY24; 26% rise in Revenue
Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs.
Pfizer Ltd Q2FY24; 52% fall in Profits
Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also
Solara Active Pharma Q4FY23 results out, revenue grows by 6%
Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs.